Evidence Level:Sensitive: D – Preclinical
New
Title:
IMMU-140, a Novel SN-38 Antibody–Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma
Excerpt:...mice bearing HLA-DRpos melanomas (A-375) were treated with IMMU-140 (Fig. 3D). Only mice treated with IMMU-140 demonstrated a significant antitumor effect when compared with all other groups (P < 0.0244; Supplementary Table S1).
DOI:https://doi.org/10.1158/1535-7163.MCT-17-0354